Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 308 of 5804
-
New targeted drug hopes to shrink NRAS-Driven cancers
Disease control Recruiting nowThis is a Phase 1 first-in-human, open-label multicenter study designed to evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics, and preliminary antitumor activity of RLY-8161, an NRAS-selective inhibitor, in participants with advanced NRAS-mutant melanoma a…
Phase: PHASE1 • Sponsor: Relay Therapeutics, Inc. • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Exercise after stroke may shield brain from dementia
Disease control Recruiting nowThe rates of cognitive decline and dementia after stroke are disproportionately high. Strategies that can protect the brain early after the stroke event could reduce the future risk of cognitive decline and dementia in these patients. Although physical exercise is usually recomme…
Phase: NA • Sponsor: McGill University • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Could a zapping helmet wake the unresponsive?
Symptom relief Recruiting nowThe goal of this clinical trial is to learn if a new type of brain stimulation called theta-burst patterned temporal interference stimulation (tTIs) works to improve awareness in people with disorders of consciousness (DoC). The main questions it aims to answer are: 1. Does tTIs…
Phase: NA • Sponsor: Zhujiang Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
New cell therapy trial targets Hard-to-Treat heart amyloidosis
Disease control Not yet recruitingRelapsed/refractory (R/R) light chain cardiac amyloidosis is associated with a poor prognosis, and cellular immunotherapy constitutes a crucial therapeutic modality for these patients. The efficacy and safety of CAR-T therapy have been reported in relevant studies; however, CAR-T…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New drug aims to tame dangerous heart rhythms in genetic disorder
Disease control Recruiting nowThe goal of this clinical trial is to learn whether the study drug THRV-1268 can safely and effectively shorten the QT interval in people diagnosed with Long QT Syndrome Type 2 (LQTS 2). The study will also learn about the safety and tolerability of THRV-1268 at different doses. …
Phase: PHASE2, PHASE3 • Sponsor: Thryv Therapeutics, Inc. • Aim: Disease control
Last updated Jul 24, 2026 00:00 UTC
-
MRI reveals how weight loss drugs reshape organs in severely obese teens
Disease control Recruiting nowThe goal of this study is to quantify the body composition and organ fat distribution changes with obesity interventions in adolescents with severe obesity. The main question the investigators aim to answer is if there is improvement in organ health with weight loss intervention.…
Sponsor: Alder Hey Children's NHS Foundation Trust • Aim: Disease control
Last updated Jul 16, 2026 00:00 UTC
-
New drug cocktail may spare kidney removal in High-Risk bladder cancer patients
Disease control Recruiting nowThis Phase II clinical trial, titled "A Phase II Trial of Sequential Gemcitabine and Mitomycin Treatment for Favorable High-Risk Upper Urinary Tract Urothelial Carcinoma (SUMMIT)," aims to evaluate the safety and effectiveness of a combination chemotherapy treatment for patients …
Phase: PHASE2 • Sponsor: Rutgers, The State University of New Jersey • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Ketamine combo may halt prolonged seizures faster
Disease control Recruiting nowThe goal of this clinical trial is to determine if treatment of patients with two doses of ketamine plus levetiracetam versus levetiracetam alone leads to more effective control of status epilepticus.
Phase: PHASE3 • Sponsor: University of Virginia • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New shot aims to cure hepatitis b – early trial underway
Disease control Recruiting nowThis study is a randomized, open-label, multicenter phase 2 clinical trial to evaluate the efficacy and safety of AHB-137 injection in participants with HBeAg-negative CHB treated with Nucleos(t)ide Analogue (NAs).
Phase: PHASE2 • Sponsor: AusperBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New hope for leukemia patients: immunotherapy added to standard care
Disease control Not yet recruitingThe goal of this trial is to provide a protocol for treatment for adults with Ph-negative acute lymphoblastic leukemia (ALL) and to learn if this provides higher probability of survival than the previous one. The main question is to know if the incorporation of blinatumomab for B…
Phase: NA • Sponsor: PETHEMA Foundation • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Shorter radiation for prostate cancer recurrence? new trial tests 2-Week option
Disease control Recruiting nowThis study is the first prospective, randomized phase III clinical trial designed to evaluate whether ultrahypofractionated radiotherapy is non-inferior to conventionally moderately hypofractionated radiotherapy in terms of efficacy, with acceptable toxicity, in patients who deve…
Phase: PHASE3 • Sponsor: Samsung Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Shingles vaccine protection tested over 6 years in 24,740 adults
Prevention Recruiting nowThis is a multicenter retrospective cohort study to evaluate the long-term effectiveness of the live attenuated herpes zoster vaccine within 6 years after vaccination. We plan to select 24,740 participants who were non-herpes zoster cases in the modified Full Analysis Set for Eff…
Sponsor: Jiangsu Province Centers for Disease Control and Prevention • Aim: Prevention
Last updated Jun 27, 2026 12:33 UTC
-
New combo therapy aims to boost immune attack on Hard-to-Treat prostate cancer
Disease control Recruiting nowThis phase I trial compares the effect of lutetium Lu 177 (177\^Lu)-prostate-specific membrane antigen (PSMA)-617 in combination with Sipuleucel-T to 177\^Lu-PSMA-617 alone in treating patients with prostate that has spread from where it first started (primary site) to other plac…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New combo therapy offers hope for tough bone cancer
Disease control Recruiting nowIn advanced osteosarcoma where traditional chemotherapy has failed, the multi-targeted tyrosine kinase inhibitor apatinib has become a mainstream systemic treatment option in China. However, for patients with a high tumor burden or extra-pulmonary lesions, these drugs are prone t…
Phase: PHASE1, PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
Radioactive antibody targets tough prostate cancer in early trial
Disease control Recruiting nowA Phase 1/2a Study to Evaluate the Safety, Tolerability, Whole-Body Distribution, and Preliminary Clinical Activity of 161Tb-RAD402, a Radiolabeled Anti-KLK3 Monoclonal Antibody Targeting Free Prostate-Specific Antigen, in Participants with Castration-Resistant Prostate Cancer (C…
Phase: PHASE1, PHASE2 • Sponsor: Radiopharm Theranostics, Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
New cell therapy trial targets Hard-to-Treat stomach cancers
Disease control Not yet recruitingThis study, a single-center, open, single-dose clinical study, was designed to evaluate the safety and efficacy of IM96 CAR-T cells in treating patients with advanced adenocarcinoma of gastric/esophagogastric junction
Phase: PHASE1 • Sponsor: Beijing Immunochina Medical Science & Technology Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
New hope for hard-to-treat colon cancer? phase 3 trial launches
Disease control Recruiting nowThe purpose of this study is to evaluate the efficacy and safety of standard-of-care chemotherapy and bevacizumab with or without INCA33890 in the first-line treatment of metastatic microsatellite stable colorectal cancer.
Phase: PHASE3 • Sponsor: Incyte Corporation • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
New drug targets liver fat and weight in obesity trial
Disease control Recruiting nowThe main objective of this trial will be to determine whether maridebart cafraglutide is superior to placebo on reduction in liver fat content and body weight in participants living with obesity or overweight and elevated liver fat content, when administered in conjunction with r…
Phase: PHASE2 • Sponsor: Amgen • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New combo therapy aims to improve survival in advanced nose cancer
Disease control Recruiting nowThis study is a multicenter, randomized, controlled phase III clinical trial aiming to investigate the efficacy and safety of Becotatug Vedotin induction therapy followed by concurrent chemoradiotherapy (CCRT) combined with neoadjuvant and adjuvant sintilimab, versus gemcitabine …
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New heart valve procedure could offer safer alternative to Open-Heart surgery for seniors
Disease control Recruiting nowThe overall purpose of ART trial is to establish the Safety and Efficacy of the J-VALVE Transcatheter Aortic Valve Replacement Versus Surgical Aortic Valve Replacement in Patients with Grade≥3+ Native Aortic Regurgitation.
Phase: NA • Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC